← United Community Banks overview

United Community Banks vs Axos Financial: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

United Community Banks, Inc. (UCB)

Q3 2026
▲3

UCB reshapes balance sheet: Navitas sold, securities repositioned, buyback raised

  • Q2 profit and revenue grew year over year UCB earned $114.9 million, or 95 cents a share, up from $76.7 million a year earlier, with revenue up about 7% to $279-280 million. Higher profit and revenue support the stock because the bank is making more money than a year ago.

    Shows the core earnings trend that underpins the stock.

  • Management guides to faster loan growth and lower costs UCB signaled roughly 7% annualized loan growth excluding Navitas in Q3, upper single-digit growth next year, and a ~$150 million quarterly expense base by Q4. More loans and lower costs mean more profit ahead, which supports the stock.

    Forward guidance on growth and expenses is a main driver of future earnings.

  • Navitas sale and securities repositioning strengthen the balance sheet UCB closed the $2.0 billion cash sale of its Navitas equipment finance unit at a 7% premium, then sold $2.6 billion of low-yielding securities and moved proceeds into ~4.5% investments. This boosts liquidity and future earnings, though it caused a ~$300 million pre-tax loss.

    The biggest strategic change of the period, directly reshaping earnings and capital.

  • Peach State merger closed; buyback raised to offset dilution UCB completed the Peach State Bancshares merger, adding $784 million in assets, and raised its buyback by $100 million, repurchasing $87 million in 2026. The deal expands the footprint but dilutes shares, so the buyback partly offsets that.

    Shows how UCB is funding growth and managing share count.

August 2026
▲3

UCB reshapes balance sheet: Navitas sold, securities repositioned, buyback raised

  • Q2 profit and revenue grew year over year UCB earned $114.9 million, or 95 cents a share, up from $76.7 million a year earlier, with revenue up about 7% to $279-280 million. Higher profit and revenue support the stock because the bank is making more money than a year ago.

    Shows the core earnings trend that underpins the stock.

  • Management guides to faster loan growth and lower costs UCB signaled roughly 7% annualized loan growth excluding Navitas in Q3, upper single-digit growth next year, and a ~$150 million quarterly expense base by Q4. More loans and lower costs mean more profit ahead, which supports the stock.

    Forward guidance on growth and expenses is a main driver of future earnings.

  • Navitas sale and securities repositioning strengthen the balance sheet UCB closed the $2.0 billion cash sale of its Navitas equipment finance unit at a 7% premium, then sold $2.6 billion of low-yielding securities and moved proceeds into ~4.5% investments. This boosts liquidity and future earnings, though it caused a ~$300 million pre-tax loss.

    The biggest strategic change of the period, directly reshaping earnings and capital.

  • Peach State merger closed; buyback raised to offset dilution UCB completed the Peach State Bancshares merger, adding $784 million in assets, and raised its buyback by $100 million, repurchasing $87 million in 2026. The deal expands the footprint but dilutes shares, so the buyback partly offsets that.

    Shows how UCB is funding growth and managing share count.

Latest
▲3

UCB reshapes balance sheet: Navitas sold, securities repositioned, buyback raised

  • Q2 profit and revenue grew year over year UCB earned $114.9 million, or 95 cents a share, up from $76.7 million a year earlier, with revenue up about 7% to $279-280 million. Higher profit and revenue support the stock because the bank is making more money than a year ago.

    Shows the core earnings trend that underpins the stock.

  • Management guides to faster loan growth and lower costs UCB signaled roughly 7% annualized loan growth excluding Navitas in Q3, upper single-digit growth next year, and a ~$150 million quarterly expense base by Q4. More loans and lower costs mean more profit ahead, which supports the stock.

    Forward guidance on growth and expenses is a main driver of future earnings.

  • Navitas sale and securities repositioning strengthen the balance sheet UCB closed the $2.0 billion cash sale of its Navitas equipment finance unit at a 7% premium, then sold $2.6 billion of low-yielding securities and moved proceeds into ~4.5% investments. This boosts liquidity and future earnings, though it caused a ~$300 million pre-tax loss.

    The biggest strategic change of the period, directly reshaping earnings and capital.

  • Peach State merger closed; buyback raised to offset dilution UCB completed the Peach State Bancshares merger, adding $784 million in assets, and raised its buyback by $100 million, repurchasing $87 million in 2026. The deal expands the footprint but dilutes shares, so the buyback partly offsets that.

    Shows how UCB is funding growth and managing share count.

Axos Financial Inc (AX)

Q3 2026
▲3

Axos beats on loan growth, guides to steady expansion

  • Q2 beat on broad loan growth Axos reported Q2 CY2026 revenue of $379.8 million, up about 21% from a year earlier, and earnings per share of $2.53, well above what analysts expected. Broad loan growth in commercial specialty and asset-based lending drove the beat, showing the bank is winning business and growing profit.

    The earnings beat and its cause are the core new fact of the period.

  • Management guides to low- to mid-teens loan growth Axos projects organic loan growth in the low- to mid-teens percentage range and a fairly stable net interest margin, with pipelines up across lending categories. New deposits from Jenius Bank and Capital One, plus the Arc deal, are expected to fund that growth, though integration costs add about $1 million a month.

    Forward guidance tells readers where future earnings are headed, not just the last quarter.

  • Verdant deal adds earnings and credit improves The Verdant Commercial Capital acquisition is contributing and management expects it to add to earnings per share at the mid-to-high end of its original estimate. Net charge-offs fell seven basis points from the prior quarter, meaning fewer loans went bad, a sign of healthier credit that supports profits.

    Deal accretion and better credit quality are new supports for the stock.

  • Strong book value growth, but one metric missed Book value per share, a key measure of a bank's underlying worth, rose 13% from a year earlier to $50.96, though it fell short of the $52.10 analysts expected. The miss is a mild counterweight to an otherwise strong quarter and is worth watching in coming reports.

    It is the one real negative in the period and keeps the picture fair.

August 2026
▲3

Axos beats on loan growth, guides to steady expansion

  • Q2 beat on broad loan growth Axos reported Q2 CY2026 revenue of $379.8 million, up about 21% from a year earlier, and earnings per share of $2.53, well above what analysts expected. Broad loan growth in commercial specialty and asset-based lending drove the beat, showing the bank is winning business and growing profit.

    The earnings beat and its cause are the core new fact of the period.

  • Management guides to low- to mid-teens loan growth Axos projects organic loan growth in the low- to mid-teens percentage range and a fairly stable net interest margin, with pipelines up across lending categories. New deposits from Jenius Bank and Capital One, plus the Arc deal, are expected to fund that growth, though integration costs add about $1 million a month.

    Forward guidance tells readers where future earnings are headed, not just the last quarter.

  • Verdant deal adds earnings and credit improves The Verdant Commercial Capital acquisition is contributing and management expects it to add to earnings per share at the mid-to-high end of its original estimate. Net charge-offs fell seven basis points from the prior quarter, meaning fewer loans went bad, a sign of healthier credit that supports profits.

    Deal accretion and better credit quality are new supports for the stock.

  • Strong book value growth, but one metric missed Book value per share, a key measure of a bank's underlying worth, rose 13% from a year earlier to $50.96, though it fell short of the $52.10 analysts expected. The miss is a mild counterweight to an otherwise strong quarter and is worth watching in coming reports.

    It is the one real negative in the period and keeps the picture fair.

Latest
▲3

Axos beats on loan growth, guides to steady expansion

  • Q2 beat on broad loan growth Axos reported Q2 CY2026 revenue of $379.8 million, up about 21% from a year earlier, and earnings per share of $2.53, well above what analysts expected. Broad loan growth in commercial specialty and asset-based lending drove the beat, showing the bank is winning business and growing profit.

    The earnings beat and its cause are the core new fact of the period.

  • Management guides to low- to mid-teens loan growth Axos projects organic loan growth in the low- to mid-teens percentage range and a fairly stable net interest margin, with pipelines up across lending categories. New deposits from Jenius Bank and Capital One, plus the Arc deal, are expected to fund that growth, though integration costs add about $1 million a month.

    Forward guidance tells readers where future earnings are headed, not just the last quarter.

  • Verdant deal adds earnings and credit improves The Verdant Commercial Capital acquisition is contributing and management expects it to add to earnings per share at the mid-to-high end of its original estimate. Net charge-offs fell seven basis points from the prior quarter, meaning fewer loans went bad, a sign of healthier credit that supports profits.

    Deal accretion and better credit quality are new supports for the stock.

  • Strong book value growth, but one metric missed Book value per share, a key measure of a bank's underlying worth, rose 13% from a year earlier to $50.96, though it fell short of the $52.10 analysts expected. The miss is a mild counterweight to an otherwise strong quarter and is worth watching in coming reports.

    It is the one real negative in the period and keeps the picture fair.